MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 81 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,835,000 | +179.6% | 5,016,164 | +99.4% | 2.15% | -10.1% |
| Q3 2019 | $3,875,000 | -25.8% | 2,516,164 | +99.9% | 2.39% | -2.0% |
| Q2 2019 | $5,225,000 | -0.7% | 1,258,964 | 0.0% | 2.44% | -20.4% |
| Q1 2019 | $5,262,000 | +45.6% | 1,258,964 | 0.0% | 3.07% | +16.8% |
| Q4 2018 | $3,613,000 | -46.3% | 1,258,964 | +87.3% | 2.63% | -48.3% |
| Q3 2018 | $6,723,000 | – | 672,271 | – | 5.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |